IAVI at the World Vaccine Congress Europe

On Oct. 28-31, more than 3,000 attendees are expected to gather in Barcelona, Spain, for the World Vaccine Congress Europe to discuss end-to-end vaccine development and progress in the field. This convening is especially timely given current events in global health – including the recent mpox and Marburg virus outbreaks, which have both called global attention to persisting vaccine distribution inequities and broader preparedness concerns. The conference agenda promises to cover these pressing themes alongside partnerships and access, manufacturing technologies, clinical trials, and other tracks facilitated by experts from across the industry.

After a successful World Vaccine Congress in Washington, D.C. earlier this year, IAVI leaders are excited to continue conversations surrounding our emerging infectious disease (EID) R&D portfolio while bringing new topics to the table. IAVI will be well-represented at this conference by Marion Gruber, Ph.D., M.S., vice president, public health and regulatory science; Swati Gupta, DrPH, MPH, vice president and head of EIDs and epidemiology; and Marlene Espinoza, Ph.D., director and product development lead, EIDs.

Gupta will kick things off at a pre-congress workshop on platform technologies, where she will participate in the “Flexible and sustainable manufacturing technologies” panel on October 28 at 12:15 CET. Next, the official first day of the congress on Oct. 29 will see Gruber co-moderate a working group on “How to generate regulatory grade RWE for vaccines” at 11:10 CET before joining a closing keynote panel, “Can uptake keep up with the speed of vaccine developments?” at 17:10 CET. Espinoza will also chair the COVID & Beyond track starting at 13:40 CET on this day.

Don’t miss the Emerging & Infectious Diseases track on Oct. 30, which will be chaired by Gupta starting at 11:10 CET. Gruber will join the track to deliver a must-see talk on “IAVI’s Lassa vaccine development: Conducting clinical trials in West Africa” at 14:40 CET. She will also speak on an AMR & Bacterial Vaccines track panel, “Where are we with current TB vaccine efforts?” earlier on day two at 11:10 CET.

Finally, on Oct. 30, Espinoza will start the day by chairing the Neglected Diseases & Global Health track beginning at 9:30 CET. She will additionally have a poster on display throughout the conference: “Intranasal Vesicular Stomatitis Virus-SARS-CoV-2 Vaccine as a Promising Path to Enhance Mucosal Immunity.” Poster sessions will occur at 13:30 CET on day one, 13:40 CET on day two, and 11:30 CET on day three.

We are looking forward to seeing you at these sessions or on IAVI’s LinkedIn and Instagram pages, where we will share major takeaways from the World Vaccine Congress Europe.